Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Interest Expenses (2019 - 2025)

Bioadaptives' Interest Expenses history spans 7 years, with the latest figure at $14153.0 for Q3 2025.

  • For Q3 2025, Interest Expenses rose 45.95% year-over-year to $14153.0; the TTM value through Sep 2025 reached $96479.0, up 6781.53%, while the annual FY2024 figure was $91978.0, 113.59% up from the prior year.
  • Interest Expenses for Q3 2025 was $14153.0 at Bioadaptives, up from $9966.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $174016.0 in Q3 2022 and bottomed at -$88132.0 in Q4 2021.
  • The 5-year median for Interest Expenses is $17969.0 (2024), against an average of $34060.8.
  • The largest annual shift saw Interest Expenses plummeted 270.76% in 2021 before it skyrocketed 1250.19% in 2023.
  • A 5-year view of Interest Expenses shows it stood at -$88132.0 in 2021, then soared by 201.61% to $89549.0 in 2022, then tumbled by 190.32% to -$80879.0 in 2023, then surged by 177.93% to $63030.0 in 2024, then crashed by 77.55% to $14153.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Interest Expenses are $14153.0 (Q3 2025), $9966.0 (Q2 2025), and $9330.0 (Q1 2025).